How McKesson Stock Gained 40%
Over nearly six months, McKesson (MCK)’s stock jumped 44%, fueled not just by solid revenue gains and a sharper profit margin, but also strategic moves—from a bold divestiture to prepping a major spin-off. Let’s unpack how strong earnings and savvy shifts combined to spark this rally.
Below is an analytical breakdown of stock movement into key contributing metrics.
| 8092025 | 2052026 | Change | |
|---|---|---|---|
| Stock Price ($) | 667.2 | 957.8 | 43.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 377,595.0 | 397,958.0 | 5.4% |
| Net Income Margin (%) | 0.8% | 1.1% | 30.1% |
| P/E Multiple | 26.3 | 27.2 | 3.2% |
| Shares Outstanding (Mil) | 124.9 | 123.2 | 1.4% |
| Cumulative Contribution | 43.6% |
So what is happening here? The stock price surged 44%, driven by a 5.4% increase in revenue, a strong 30% boost in net margin, and a modest 3.2% rise in the P/E multiple. Let’s dive into what’s behind these numbers.
Here Is Why McKesson Stock Moved
- This Strategy Pays You 10.0% While Lining Up LRCX at Bargain Prices
- Catalysts That Could Propel UnitedHealth Stock to the Moon
- What Could Go Wrong With Intel Stock?
- Cash Machine Trading Cheap – Docusign Stock Set to Run?
- Applied Materials Stock’s Winning Streak May Not Be Over Yet
- T-Mobile US Stock Now 21% Cheaper, Time To Buy
- Strong Q2 FY26 Earnings: EPS beat, record revenue, and raised full-year guidance for FY2026. Stock rose 0.31%.
- Positive Q3 FY26 Earnings: Adjusted EPS and revenue beat estimates; guidance raised again. Noted weaker cash flow.
- Norway Divestiture: Completed sale of Norwegian businesses on Jan 30, 2026, exiting Europe. Focuses core growth.
- Org Structure Change: New organizational structure announced Sept 18, 2025, to boost oncology/specialty growth.
- Med-Surg Spin-Off Prep: Progress on planned Medical-Surgical segment IPO in Jan 2026, for 2027 completion.
Our Current Assesment Of MCK Stock
Opinion: We currently find MCK stock fairly priced. Why so? Have a look at the full story. Read Buy or Sell MCK Stock to see what drives our current opinion.
Risk: A solid way to gauge risk in MCK is to check its drops in past market stress periods. It plunged over 81% in the Dot-Com crash and slid nearly 58% during the Global Financial Crisis. The 2018 selloff saw a decline of about 38%, while the Covid pandemic brought a 32% dip. Even the recent inflation shock caused a pullback of 15%. So, even with all the positives around, MCK hasn’t been immune to deep declines when markets turn sour.
MCK stock may have seen strong gains recently, but investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.